$1.16
+0.00 (+0.00%)
Open$1.20
Previous Close$1.16
Day High$1.20
Day Low$1.14
52W High$32.43
52W Low$19.15
Volume—
Avg Volume115.7K
Market Cap275.36M
P/E Ratio51.92
EPS$0.58
SectorBiotechnology
Analyst Ratings
Strong Buy
8 analysts
Price Target
+3,068.1% upside
Current
$1.16
$1.16
Target
$36.75
$36.75
$26.33
$36.75 avg
$40.94
Key Financials
| FY 2025 | FY 2024 | FY 2023 | |
|---|---|---|---|
| Revenue | 40.60M | 42.46M | 39.37M |
| Net Income | -1,409,045 | -1,565,662 | -1,719,749 |
| Profit Margin | -3.5% | -3.7% | -4.4% |
| EBITDA | -2,559,719 | -2,552,246 | -2,827,370 |
| Free Cash Flow | -1,137,405 | -963,691 | -1,418,550 |
| Rev Growth | +15.5% | -1.3% | +12.3% |
| Debt/Equity | 0.48 | 0.77 | 0.57 |
Biotechnology Peers
| Symbol | Name | Price | Change | P/E | Mkt Cap |
|---|---|---|---|---|---|
| ABBV | Abbvie Inc | $223.43 | +2.01% | 165.4 | 394.89B |
| AMGN | Amgen Inc | $384.32 | +4.49% | 26.8 | 206.95B |
| GILD | Gilead Sciences Inc | $152.50 | +2.10% | 23.3 | 189.20B |
| VRTX | Vertex Pharmaceuticals Inc | $477.92 | +4.17% | 33.7 | 123.82B |
| REGN | Regeneron Pharmaceuticals | $785.51 | +2.46% | 18.4 | 83.03B |
| ALNY | Alnylam Pharmaceuticals Inc | $328.16 | -0.93% | 995.2 | 43.35B |